Literature DB >> 19552751

Comparing patients' and healthcare professionals' ADR reports after media attention: the broadcast of a Dutch television programme about the benefits and risks of statins as an example.

Florence van Hunsel1, Anneke Passier, Kees van Grootheest.   

Abstract

AIMS: To compare adverse drug reaction (ADR) reports from patients and health professionals after the broadcast of a Dutch television consumer programme about the benefits and risks of statins.
METHODS: We performed a quantitative and qualitative analysis on patients' and health professionals' reports of ADRs to statins. These reports were received by the Netherlands Pharmacovigilance Centre Lareb between March 2007 and August 2007. Quantitative data consisted of patient age and gender, number of received reports and characteristics of the report (most frequently reported ADRs, seriousness, drug discontinuation and outcome of the reported reaction). Open text fields in the ADR reporting form were categorized and a content analysis was carried out.
RESULTS: Media attention led to a peak in patient reporting of ADRs but not in reporting by health professionals. There were no differences between patient and health professional reports in seriousness of the ADRs and drug cessation. Patients reported nonrecovery more often than health professionals. The TV programme is mentioned as a reason for drug discontinuation in almost 30 reports. Patients often felt that they did not receive sufficient information and that their concerns were not adequately addressed by healthcare professionals.
CONCLUSIONS: Media attention affects drug use and ADR reporting by patients. Patient reports can provide additional information, making them a useful source of information next to health professional reports. Content analysis provides vital insights into the impact of statins on daily life, and patients' concerns about adverse reactions should be recognized in reports to national pharmacovigilance centres.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19552751      PMCID: PMC2686073          DOI: 10.1111/j.1365-2125.2009.03400.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  18 in total

1.  Spontaneous reporting--of what? Clinical concerns about drugs.

Authors:  I R Edwards
Journal:  Br J Clin Pharmacol       Date:  1999-08       Impact factor: 4.335

Review 2.  Qualitative research in health care. Analysing qualitative data.

Authors:  C Pope; S Ziebland; N Mays
Journal:  BMJ       Date:  2000-01-08

Review 3.  The medical dictionary for regulatory activities (MedDRA).

Authors:  E G Brown; L Wood; S Wood
Journal:  Drug Saf       Date:  1999-02       Impact factor: 5.606

4.  Effects of coding dictionary on signal generation: a consideration of use of MedDRA compared with WHO-ART.

Authors:  Elliot G Brown
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

5.  Influence of the third generation pill controversy on prescriptions for oral contraceptives among first time users: population based study.

Authors:  Lolkje de Jong-van den Berg; Hilde Tobi; Bert Bijker; Paul van den Berg
Journal:  BMJ       Date:  2003-02-01

6.  "Serious" and "severe" adverse drug reactions need defining.

Authors:  Christian Frankenfeld
Journal:  BMJ       Date:  2004-09-04

7.  Seriousness of adverse events: medical judgment is important.

Authors:  Javier Borja; Esther Donado; Mario Souto
Journal:  BMJ       Date:  2004-12-11

Review 8.  Qualitative research methods in general practice and primary care.

Authors:  N Britten; R Jones; E Murphy; R Stacy
Journal:  Fam Pract       Date:  1995-03       Impact factor: 2.267

Review 9.  Patients' role in reporting adverse drug reactions.

Authors:  Kees van Grootheest; Lolkje de Jong-van den Berg
Journal:  Expert Opin Drug Saf       Date:  2004-07       Impact factor: 4.250

10.  Adverse drug reaction reporting by patients in the Netherlands: three years of experience.

Authors:  Joyce de Langen; Florence van Hunsel; Anneke Passier; Lolkje de Jong-van den Berg; Kees van Grootheest
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

View more
  32 in total

Review 1.  Experiences with adverse drug reaction reporting by patients: an 11-country survey.

Authors:  Florence van Hunsel; Linda Härmark; Shanthi Pal; Sten Olsson; Kees van Grootheest
Journal:  Drug Saf       Date:  2012-01-01       Impact factor: 5.606

2.  Two cheers or three for treatment guidelines? Nudging prescribers in right directions.

Authors:  Yoon K Loke; James M Ritter
Journal:  Br J Clin Pharmacol       Date:  2011-12       Impact factor: 4.335

Review 3.  ADR Reporting by the General Public: Lessons Learnt from the Dutch and Swedish Systems.

Authors:  Linda Härmark; Florence van Hunsel; Birgitta Grundmark
Journal:  Drug Saf       Date:  2015-04       Impact factor: 5.606

4.  Statin adverse effects: patients' experiences and laboratory monitoring of muscle and liver injuries.

Authors:  Nataporn Chaipichit; Janet Krska; Thongchai Pratipanawatr; Narumol Jarernsiripornkul
Journal:  Int J Clin Pharm       Date:  2015-01-29

5.  Consumer reporting of adverse drug reactions: Systems that allow patients to report side effects of the drugs they are taking have yielded valuable information for improving drugs safety and health care.

Authors:  Katrin Weigmann
Journal:  EMBO Rep       Date:  2016-05-19       Impact factor: 8.807

Review 6.  Direct reporting of adverse drug reactions by healthcare consumers in Africa: a narrative review.

Authors:  Halimat Adedeji-Adenola; Manimbulu Nlooto
Journal:  Int J Clin Pharm       Date:  2020-09-09

Review 7.  Web-based patient-reported outcomes in drug safety and risk management: challenges and opportunities?

Authors:  Anjan K Banerjee; Simon Ingate
Journal:  Drug Saf       Date:  2012-06-01       Impact factor: 5.606

Review 8.  The value of patient reporting to the pharmacovigilance system: a systematic review.

Authors:  Pedro Inácio; Afonso Cavaco; Marja Airaksinen
Journal:  Br J Clin Pharmacol       Date:  2016-10-12       Impact factor: 4.335

9.  Effect of pharmacist involvement on patient reporting of adverse drug reactions: first Italian study.

Authors:  Roberto Leone; Ugo Moretti; Paola D'Incau; Anita Conforti; Lara Magro; Riccardo Lora; Giampaolo Velo
Journal:  Drug Saf       Date:  2013-04       Impact factor: 5.606

10.  First French experience of ADR reporting by patients after a mass immunization campaign with Influenza A (H1N1) pandemic vaccines: a comparison of reports submitted by patients and healthcare professionals.

Authors:  Geneviève Durrieu; Aurore Palmaro; Laure Pourcel; Céline Caillet; Angeline Faucher; Alexis Jacquet; Shéhérazade Ouaret; Marie Christine Perault-Pochat; Carmen Kreft-Jais; Anne Castot; Maryse Lapeyre-Mestre; Jean-Louis Montastruc
Journal:  Drug Saf       Date:  2012-10-01       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.